BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4675425)

  • 21. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
    Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W; Li J; Ma CM
    Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Principles and indications of methods of irradiation in oncology].
    Bey P
    Rev Prat; 1989 Nov; 39(27):2444-8. PubMed ID: 2481335
    [No Abstract]   [Full Text] [Related]  

  • 24. [Introduction in the problem of the time factor and its therapeutical significance (author's transl)].
    Hug O
    Strahlentherapie; 1977 Jun; 153(6):362-70. PubMed ID: 877972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation biology at clinically relevant fractions.
    Peters LJ; Brock WA; Travis EL
    Important Adv Oncol; 1990; ():65-83. PubMed ID: 2182524
    [No Abstract]   [Full Text] [Related]  

  • 26. [Late complications of radiotherapy: a century-old challenge?].
    Cosset JM
    Bull Cancer Radiother; 1995; 82(2):85-7. PubMed ID: 7546898
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibilities of development of complications of radiation therapy in patients with malignant tumors].
    Pavlov AS; Datsenko VS; Fadeeva MA; Zamiatin OA
    Med Radiol (Mosk); 1980 Apr; 25(4):8-13. PubMed ID: 7382766
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radiosensitivity of malignant neoplasms].
    Balmukhanov SB; Efimov ML
    Med Radiol (Mosk); 1973 Dec; 18(12):65-7. PubMed ID: 4790962
    [No Abstract]   [Full Text] [Related]  

  • 29. [Interval of radiosensitivity as a basis of therapeutic irradiation of malignant tumors].
    Kholin VV
    Med Radiol (Mosk); 1973 Dec; 18(12):71-7. PubMed ID: 4364513
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimization of radiotherapy. Report of a WHO meeting of investigators.
    World Health Organ Tech Rep Ser; 1980; 644():1-89. PubMed ID: 6770556
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology.
    Bentzen SM
    Cancer Treat Res; 2008; 139():41-62. PubMed ID: 18236711
    [No Abstract]   [Full Text] [Related]  

  • 33. [Low dose rate accelerated radiation therapy].
    Pierquin B; Tubiana M;
    Cancer Radiother; 2007 Dec; 11(8):441-2. PubMed ID: 18029215
    [No Abstract]   [Full Text] [Related]  

  • 34. [Late progressive radiation myelopathies. A study of 27 cases].
    Combes PF; Daly N; Schlienger M; Humeau F
    J Radiol Electrol Med Nucl; 1975 Nov; 56(11):815-25. PubMed ID: 815547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of multiple daily doses in radiotherapy: hyperfractionation].
    Girinsky T; Cosset JM; Malaise EP
    Rev Prat; 1990 Mar; 40(8):735-7. PubMed ID: 2320899
    [No Abstract]   [Full Text] [Related]  

  • 36. TCP and NTCP: a basic introduction.
    Baumann M; Petersen C
    Rays; 2005; 30(2):99-104. PubMed ID: 16294901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interplay of radiocurability and tolerance in the irradiation of human cancers.
    Fletcher GH; Shukovsky LJ
    J Radiol Electrol Med Nucl; 1975 May; 56(5):383-400. PubMed ID: 1177184
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality assurance of radiotherapy in clinical trials.
    Glicksman AS; Reinstein LE; Laurie F
    Cancer Treat Rep; 1985 Oct; 69(10):1199-205. PubMed ID: 4042099
    [No Abstract]   [Full Text] [Related]  

  • 39. [The determination of the optimal irradiation dose in the tumor tissue-normal body tissues system].
    Klepper LIa
    Med Tekh; 1997; (4):18-21. PubMed ID: 9379858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radiation tolerance dose of the spinal cord following conventionally fractionated irradiation].
    Yamada S; Hoshi A; Takai Y; Hoshino F; Mochizuki Y; Kanehira C; Kaneta K
    Gan No Rinsho; 1987 Aug; 33(10):1189-92. PubMed ID: 3669312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.